RenewVax raises €690K Seed round

11 November 2022· Liverpool, United Kingdom· health, biotech, ai, b2b, deep_hardware

The funding will be used to complete pre-clinical studies for a novel pneumococcal vaccine and to support the spin-out venture as it prepares for clinical development.

Investors

LeadInnovate UK

Also participating

University of Liverpool

About RenewVax

Stage

Seed

Headquarters

Liverpool, United Kingdom

Founded

2022

Team Size

6–20

Sectors

healthbiotechaib2bdeep_hardware

https://www.renewvax.com/

Source: https://news.liverpool.ac.uk/2022/11/11/university-spin-out-to-develop-next-generation-pneumococcal-vaccines/